← Eichor
Study identifier: NCT05569681 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients

Condition: Morbid Obesity  ·  Sponsor: Hawler Medical University

PhaseNA
Planned participants2400
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersYes

About this study

Morbid obesity, is known to be associated with a high risk of VTE and, unfortunately, fixed doses of anticoagulant regimens may not provide optimal VTE prophylaxis in these patients especially after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Shahla ALALAF  ·  07504480711  ·  shahla_alaf@yahoo.com

Abu bakir Majeed  ·  07504494656  ·  abubakir.majeed@hmu.edu.krd

Always discuss trial participation with your own doctor first.

Locations (1)

Hawler Medical universityErbil, Kurdistan Region, IraqRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05569681